Sickle cell bone disease and response to intravenous bisphosphonates in children

ConclusionChildren with SCD have the potential for extensive and early-onset bone morbidity. In this series, IV bisphosphonates were effective for bone pain analgesia and did not trigger sickle cell complications.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research